Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;46(3):246-52.
doi: 10.4132/KoreanJPathol.2012.46.3.246. Epub 2012 Jun 22.

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas

Affiliations

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas

Hyoun Wook Lee et al. Korean J Pathol. 2012 Jun.

Abstract

Background: This study was conducted to clarify the frequency of the BRAF mutation in primary melanomas and its correlation with clinicopathologic parameters.

Methods: We analyzed the frequency of BRAF mutation in patients with primary cutaneous melanoma (n=58) or non-cutaneous one (n=27) by performing dual priming oligonucleotide-based multiplex real-time polymerase chain reaction to isolate and to purify the DNA from the formalin-fixed and paraffin-embedded tumors.

Results: The BRAF mutation was found in 17.2% (10/58) of patients with primary cutaneous melanoma and 11.1% (3/27) of those with non-cutaneous melanoma. The frequency of BRAF mutation was not correlated with any clinicopathologic parameters with the exception of the patient age. The frequency of the BRAF mutation was significantly higher in patients younger than 60 years as compared with those older than 60 years (p=0.005).

Conclusions: Compared with previous reports, our results showed that the frequency of the BRAF mutation was relatively lower in patients with primary cutaneous melanoma. Besides, our results also showed that the frequency of the BRAF mutation had an inverse correlation with the age. Further studies are warranted to exclude methodological bias, to elucidate the difference in the frequency of the BRAF mutation from the previous reports from a Caucasian population and to provide an improved understanding of the molecular pathogenesis of malignant melanoma.

Keywords: BRAF; Frequency; Melanoma; Mutation.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Representative results from the real-time polymerase chain reaction assay for the detection of the BRAF mutation. Two blue curves represent mutant probes and the other brown curves do wild type ones. All of them have a cycle threshold value of <40.
Fig. 2
Fig. 2
Kaplan-Meier survival curves for overall survival (A) and disease-free survival (B) stratified by the BRAF mutation in primary cutaneous melanoma.

Similar articles

Cited by

References

    1. Kim HS, Cho EA, Bae JM, et al. Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006. J Korean Med Sci. 2010;25:924–929. - PMC - PubMed
    1. Miller AJ, Mihm MC., Jr Melanoma. N Engl J Med. 2006;355:51–65. - PubMed
    1. Chabner BA. Biological basis for cancer treatment. Ann Intern Med. 1993;118:633–637. - PubMed
    1. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954. - PubMed
    1. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–6206. - PMC - PubMed